Takeda Canada Inc.
6 meetings with public office holders, Apr 15, 2026 to Jun 9, 2026.
39 meetings on record since 2019, their first on record.
Meetings over time
- Apr 2026: 1 meeting, with Ritu Banerjee, Maggie Chi, Elizabeth Wong, Annahat Kochhar, Nasser Haidar
- May 2026: 1 meeting, with Bernard Généreux
- Jun 2026: 4 meetings, with Aslam Rana, Arianne Reza, Joelle Paquette, Anie Perrault, Shalene Curtis-Micallef
Apr 2026peak 4 in a monthJun 2026
Hover or focus a month to see who was met.
What they lobby about
- Health6
- Internal Trade4
- Industry2
- Intellectual Property2
- Federal-Provincial Relations1
- Research and Development1
- Science and Technology1
The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.
Who they met
Liberal2 met · 2 meetings
Conservative1 met · 1 meeting
Not in Arena's member list15 met · 23 meetings
- Elizabeth Wong
- Jocelyne Voisin
- Justine Frame
- Mackenzy Metcalfe
- Pamela Aung-Thin
- Ritu Banerjee
- Sandenga Yeba
- Shalene Curtis-Micallef
- Anie Perrault
- Annahat Kochhar
- Arianne Reza
- Joelle Paquette
- Kaili Levesque
- Linsey Hollett
- Nasser Haidar
Health Canada (HC) (11) · Treasury Board Of Canada Secretariat (TBS) (3) · House of Commons (3) · Finance Canada (FIN) (2) · Innovation, Science and Economic Development Canada (ISED) (2) · Patented Medicine Prices Review Board (PMPRB) (1)
In their own words
- Engagement on federal policies and programmes related to the availability, appropriate use, and continuity of supply of plasma?derived therapies, including immunoglobulins, for patients with immune?mediated and rare conditions.
- Pharmaceutical pricing policy considerations within the mandate of the Patented Medicine Prices Review Board (PMPRB), including regulatory amendments and associated guidance.
- Engagement on international trade discussions and policies that may impact access to medicines and the security of drug supply in Canada.
Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.